| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | VANDA PHARMACEUTICALS INC COM | 1,715,000 | 19,345,000 | 7.65% | ||
| 2 | FIVE PRIME THERAPEUTICS INC | 1,226,785 | 18,880,000 | 7.47% | ||
| 3 | CONNECTURE INC COM | 4,127,232 | 18,820,000 | 7.44% | ||
| 4 | ADAMAS PHARMACEUTICALS INC | 1,110,000 | 18,581,000 | 7.35% | ||
| 5 | ZOGENIX INC | 1,362,763 | 18,397,000 | 7.28% | ||
| 6 | DYAX CORP COM CVR | 750,000 | 14,318,000 | 5.66% | ||
| 7 | RELYPSA INC | 769,047 | 14,235,000 | 5.63% | ||
| 8 | GW PHARMACEUTICALS PLC | 103,800 | 9,484,000 | 3.75% | Call | |
| 9 | GW PHARMACEUTICALS PLC | 100,000 | 9,137,000 | 3.61% | Put | |
| 10 | EXELIXIS INC | 1,590,000 | 8,920,000 | 3.53% | ||
| 11 | PARATEK PHARMACEUTICALS INC | 453,878 | 8,624,000 | 3.41% | ||
| 12 | TETRAPHASE PHARMACEUTICALS I COM | 1,120,000 | 8,355,000 | 3.30% | ||
| 13 | RAPTOR PHARMACEUTICAL CORP | 1,335,000 | 8,077,000 | 3.19% | ||
| 14 | ALCOBRA LTD | 1,205,183 | 7,279,000 | 2.88% | ||
| 15 | ARADIGM CORP COM | 1,002,962 | 7,221,000 | 2.86% | ||
| 16 | AURINIA PHARMACEUTICALS INC | 2,457,144 | 6,917,000 | 2.74% | ||
| 17 | OCERA THERAPEUTICS INC | 1,963,777 | 6,206,000 | 2.45% | ||
| 18 | SYNERGY PHARMACEUTICALS DEL COM NEW | 1,135,580 | 6,019,000 | 2.38% | ||
| 19 | MEDICINES CO | 150,000 | 5,694,000 | 2.25% | ||
| 20 | VERICEL CORP | 2,086,028 | 5,653,000 | 2.24% | ||
| 21 | Bovie Medical Corp | 2,680,000 | 5,226,000 | 2.07% | ||
| 22 | STEMLINE THERAPEUTICS INC | 475,200 | 4,196,000 | 1.66% | ||
| 23 | ALIMERA SCIENCES INC | 1,683,162 | 3,720,000 | 1.47% | ||
| 24 | Caladrius Biosciences Inc | 2,248,781 | 3,351,000 | 1.33% | ||
| 25 | TENAX THERAPEUTICS INC COM | 1,108,593 | 3,326,000 | 1.32% | ||
| 26 | Sunesis Pharmaceuticals I | 3,250,000 | 2,633,000 | 1.04% | ||
| 27 | ANTARES PHARMA INC | 1,018,627 | 1,732,000 | 0.69% | ||
| 28 | BIODEL INC | 3,316,966 | 1,459,000 | 0.58% | ||
| 29 | Aquinox Pharmaceuticals Inc | 100,000 | 1,407,000 | 0.56% | ||
| 30 | OSIRIS THERAPEUTICS INC NEW COM | 75,000 | 1,385,000 | 0.55% | ||
| 31 | FLEXION THERAPEUTICS INC COM | 66,300 | 985,000 | 0.39% | Call | |
| 32 | THRESHOLD PHARMACEUTICAL INC | 210,800 | 858,000 | 0.34% | Call | |
| 33 | TRANSITION THERAPEUTICS INC | 447,026 | 800,000 | 0.32% | ||
| 34 | DISCOVERY LABORATORIES INC N | 2,530,532 | 759,000 | 0.30% | ||
| 35 | DERMA SCIENCES INC COM PAR .01 | 101,235 | 477,000 | 0.19% | ||
| 36 | STREAMLINE HEALTH SOLUTIONS COM | 151,611 | 347,000 | 0.14% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000930413-15-004329, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
